133 related articles for article (PubMed ID: 8412301)
21. Modulation of gene expression in the acute promyelocytic leukemia cell line NB4.
Hu ZB; Ma W; Uphoff CC; Lanotte M; Drexler HG
Leukemia; 1993 Nov; 7(11):1817-23. PubMed ID: 7901456
[TBL] [Abstract][Full Text] [Related]
22. Induction of differentiation of B-cell leukemia cell lines JVM-2 and EHEB by bryostatin 1.
Hu ZB; Gignac SM; Uphoff CC; Quentmeier H; Steube KG; Drexler HG
Leuk Lymphoma; 1993 May; 10(1-2):135-42. PubMed ID: 8374521
[TBL] [Abstract][Full Text] [Related]
23. Two protein kinase C activators, bryostatin-1 and phorbol-12-myristate-13-acetate, have different effects on haemopoietic cell proliferation and differentiation.
Ng SB; Guy GR
Cell Signal; 1992 Jul; 4(4):405-16. PubMed ID: 1419483
[TBL] [Abstract][Full Text] [Related]
24. 1alpha,25-dihydroxyvitamin D3 and bryostatin-1 synergize to induce monocytic differentiation of NB4 acute promyelocytic leukemia cells by modulating cell cycle progression.
Clark CS; Konyer JE; Meckling KA
Exp Cell Res; 2004 Mar; 294(1):301-11. PubMed ID: 14980523
[TBL] [Abstract][Full Text] [Related]
25. Modulation by staurosporine of phorbol-ester-induced effects on growth and protein kinase C localization in A549 human lung-carcinoma cells.
Bradshaw TD; Gescher A; Pettit GR
Int J Cancer; 1992 Apr; 51(1):144-8. PubMed ID: 1563835
[TBL] [Abstract][Full Text] [Related]
26. Involvement of phospholipase D and protein kinase C in phorbol ester and fatty acid stimulated turnover of phosphatidylcholine and phosphatidylethanolamine in neural cells.
Cook HW; Ridgway ND; Byers DM
Biochim Biophys Acta; 1998 Feb; 1390(1):103-17. PubMed ID: 9487144
[TBL] [Abstract][Full Text] [Related]
27. Protein kinase C activation modulates pro- and anti-apoptotic signaling pathways.
Meinhardt G; Roth J; Totok G
Eur J Cell Biol; 2000 Nov; 79(11):824-33. PubMed ID: 11139146
[TBL] [Abstract][Full Text] [Related]
28. Bryostatin 1, an activator of protein kinase C, mimics as well as inhibits biological effects of the phorbol ester TPA in vivo and in vitro.
Gschwendt M; Fürstenberger G; Rose-John S; Rogers M; Kittstein W; Pettit GR; Herald CL; Marks F
Carcinogenesis; 1988 Apr; 9(4):555-62. PubMed ID: 2451575
[TBL] [Abstract][Full Text] [Related]
29. Activation of T-cells by bryostatins: induction of the IL-2 receptor gene transcription and down-modulation of surface receptors.
Esa AH; Boto WO; Adler WH; May WS; Hess AD
Int J Immunopharmacol; 1990; 12(5):481-90. PubMed ID: 2210911
[TBL] [Abstract][Full Text] [Related]
30. Establishment and characterization of two novel cytokine-responsive acute myeloid and monocytic leukemia cell lines, MUTZ-2 and MUTZ-3.
Hu ZB; Ma W; Zaborski M; MacLeod R; Quentmeier H; Drexler HG
Leukemia; 1996 Jun; 10(6):1025-40. PubMed ID: 8667638
[TBL] [Abstract][Full Text] [Related]
31. The effect of fetal calf serum on growth arrest caused by activators of protein kinase C.
Bradshaw TD; Gescher A; Pettit GR
Int J Cancer; 1991 Apr; 47(6):929-32. PubMed ID: 1707036
[TBL] [Abstract][Full Text] [Related]
32. Human THP-1 monocytic leukemic cells induced to undergo monocytic differentiation by bryostatin 1 are refractory to proteasome inhibitor-induced apoptosis.
Chen C; Lin H; Karanes C; Pettit GR; Chen BD
Cancer Res; 2000 Aug; 60(16):4377-85. PubMed ID: 10969781
[TBL] [Abstract][Full Text] [Related]
33. The transient increase of tight junction permeability induced by bryostatin 1 correlates with rapid downregulation of protein kinase C-alpha.
Clarke H; Ginanni N; Laughlin KV; Smith JB; Pettit GR; Mullin JM
Exp Cell Res; 2000 Nov; 261(1):239-49. PubMed ID: 11082294
[TBL] [Abstract][Full Text] [Related]
34. Bryostatin 1 activates protein kinase C and induces monocytic differentiation of HL-60 cells.
Stone RM; Sariban E; Pettit GR; Kufe DW
Blood; 1988 Jul; 72(1):208-13. PubMed ID: 2455568
[TBL] [Abstract][Full Text] [Related]
35. Evidence of a functional role for the cyclin-dependent kinase inhibitor p21(WAF1/CIP1/MDA6) in the reciprocal regulation of PKC activator-induced apoptosis and differentation in human myelomonocytic leukemia cells.
Wang Z; Su ZZ; Fisher PB; Wang S; VanTuyle G; Grant S
Exp Cell Res; 1998 Oct; 244(1):105-16. PubMed ID: 9770354
[TBL] [Abstract][Full Text] [Related]
36. Modulation of protein kinase C activity and calcium-sensitive isoform expression in human myeloid leukemia cells by bryostatin 1: relationship to differentiation and ara-C-induced apoptosis.
Grant S; Turner AJ; Freemerman AJ; Wang Z; Kramer L; Jarvis WD
Exp Cell Res; 1996 Oct; 228(1):65-75. PubMed ID: 8892972
[TBL] [Abstract][Full Text] [Related]
37. Phorbol esters activate proteoglycan metabolism in human colon cancer cells en route to terminal differentiation.
McBain JA; Pettit GR; Mueller GC
Cell Growth Differ; 1990 Jun; 1(6):281-91. PubMed ID: 2278882
[TBL] [Abstract][Full Text] [Related]
38. Effects of activators of protein kinase C, including bryostatins 1 and 2, on the growth of A549 human lung carcinoma cells.
Dale IL; Gescher A
Int J Cancer; 1989 Jan; 43(1):158-63. PubMed ID: 2910827
[TBL] [Abstract][Full Text] [Related]
39. Effects of bryostatin-5 and hematopoietic growth factors on acute myeloid leukemia cell differentiation, proliferation, and primary plating efficiency.
van der Hem KG; Dräger AM; Odding JH; Huijgens PC
Leuk Res; 1995 Sep; 19(9):651-7. PubMed ID: 7564476
[TBL] [Abstract][Full Text] [Related]
40. Bryostatin 1 and phorbol ester down-modulate protein kinase C-alpha and -epsilon via the ubiquitin/proteasome pathway in human fibroblasts.
Lee HW; Smith L; Pettit GR; Smith JB
Mol Pharmacol; 1997 Mar; 51(3):439-47. PubMed ID: 9058599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
